About Science Angel Syndicate
Science Angel Syndicate, established in 2021, is an angel investment group based in Bristol, United Kingdom. It primarily focuses on Seed investments in companies in United Kingdom. Its portfolio includes 9 firms, spanning the Life Sciences, HealthTech sectors. Its most notable investments include companies like OSSTEC, MitoRx Therapeutics and QV Bioelectronics. Its latest investment was a $687K Seed round in Zentraxa on Apr 07, 2025, which also saw participation from Bristol Private Equity Club and Future Planet Capital.
To date, 33 investors have co-invested in Science Angel Syndicate's portfolio companies, including prominent names like Elbow Beach Capital.
Key Metrics
Founded Year
2021
Location
Bristol, United Kingdom
Portfolio Companies
Sectors of Investment
Stages of Investment
Seed
Locations of Investment
Science Angel Syndicate's List of Top Investments
Science Angel Syndicate has a portfolio of 9 companies. Their most notable investments are in MitoRx Therapeutics and EnsiliTech.Their portfolio spans across United Kingdom and China. They have invested in Life Sciences, HealthTech, High Tech and 3 other sectors, across stages such as Seed stage. Here is the list of top investments by Science Angel Syndicate:1. OSSTEC
Developer of regenerative orthopedic implants. The company specializes in bone healing technology and offers partial knee implants that stimulate long-term bone growth.
Key facts about OSSTEC
- Founded Year: 2021
- Location: London (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $4.68M
- Employee Count: 21 as on Aug 31, 2026
- Investors: SFC Capital, Parkwalk and 10 Others
- Latest Funding Round: Series A, Apr 08, 2025, $*****
- Highlight: Editors' Pick
Developer of new treatments to restore healthy mitochondrial metabolism in patients. The company's small molecule asset, MTRX31, targets the elimination of ectopic fat from affected organs, in people with metabolically unhealthy obesity, by resetting mitochondrial function rather than suppressing appetite.
Key facts about MitoRx Therapeutics
- Founded Year: 2021
- Location: Harwell (United Kingdom)
- Stage: Seed
- Total Funding till date: $12.2M
- Employee Count: 19 as on Sep 30, 2026
- Investors: Wren Capital, Longevitytech.fund and 21 Others
- Latest Funding Round: Seed, Nov 17, 2025, $*****
- Highlight: Editors' Pick
Manufacturer of electrotherapy devices for treating brain tumors. The company's flagship product is GRACE, an implanted device that delivers electric field therapy directly to the tumour resection margins where GBM recurrence takes place.
Key facts about QV Bioelectronics
- Founded Year: 2019
- Location: Manchester (United Kingdom)
- Stage: Series A
- Total Funding till date: $9.63M
- Employee Count: 18 as on Aug 31, 2026
- Investors: SOSV, Ukri and 18 Others
- Latest Funding Round: Series A, Jan 21, 2026, $*****

4. cheMastery
Developer of automation systems for chemical laboratories. Its products facilitate the manufacturing and research and development processes in the chemical industry.
Key facts about cheMastery
- Founded Year: 2018
- Location: London (United Kingdom)
- Stage: Seed
- Total Funding till date: $250K
- Employee Count: 11 as on Sep 30, 2026
- Investors: Shift, Entrepreneurs First and 18 Others
- Latest Funding Round: Seed, Jun 2023, $*****
5. Wase
Developer of modular electro-methanogenic biogas technology. This technology enhances biogas production from waste streams, offering a more efficient and compact solution compared to traditional anaerobic digestion. The system is designed for seamless integration into existing operations and includes ongoing maintenance and optimization services. It is applicable across various sectors, including food and beverage processing, agriculture, and brewing. The technology aims to improve methane yields, reduce waste treatment costs, and increase energy production from waste byproducts.
Key facts about Wase
- Founded Year: 2017
- Location: Bristol (United Kingdom)
- Annual Revenue: £0 - £1M as on Mar 31, 2025
- Stage: Series A
- Total Funding till date: $16.6M
- Employee Count: 51 as on Aug 31, 2026
- Investors: ENGIE New Ventures, Empirical Ventures and 10 Others
- Latest Funding Round: Conventional Debt, Mar 27, 2024, $*****
- Highlight: Editors' Pick
Science Angel Syndicate's Year-on-Year Investment Trends
In 2025, it made 1 investment. Its most recent first time investment was in Halo Therapeutics and most recent follow-on round was in Zentraxa.Science Angel Syndicate's Investments by Stage
Science Angel Syndicate has made 9 investments in Seed stage with an average round size of $1.41M.Science Angel Syndicate's Investments by Sector
Science Angel Syndicate has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Sustainability Tech, Chemicals and Materials Tech and Environment Tech. Notably, it has invested in 8 Enterprise (B2B) companies, 8 Tech companies, 4 Tech hardware companies and at least 2 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 5 |
High Tech | 3 |
Sustainability Tech | 3 |
Chemicals and Materials Tech | 2 |
Environment Tech | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
Science Angel Syndicate's Investments by Geography
Science Angel Syndicate has made most investments in United Kingdom (8), followed by China where it has made 1 investment.Country | No. of Investments |
|---|---|
United Kingdom | 8 |
China | 1 |
Note: We have considered here, only first round of investments
Science Angel Syndicate's recent investments
Science Angel Syndicate has not made any investment in 2026 so far.Here are the most recent investments by Science Angel Syndicate:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 07, 2025 | United Kingdom | Seed | 7242 | ||
Dec 13, 2023 | United Kingdom | Seed | 9474 | ||
May 22, 2023 | United Kingdom | Seed | 4375 | ||
Apr 03, 2023 | United Kingdom | Seed | 1337 | [+4] | |
Jan 17, 2023 | China | Seed | 2167 | [+3] |
Team profile of Science Angel Syndicate
Science Angel Syndicate has a team of 1 member located in United Kingdom. Science Angel Syndicate's team does not sit on the board of any company as of now.Co-investors of Science Angel Syndicate
Over the past 4 years, 55 investors have co-invested in Science Angel Syndicate's portfolio companies. This includes funds and angels.
- Invested before Science Angel Syndicate: Consilience Ventures, SOSV and 3 others have invested in rounds before Science Angel Syndicate. There is 1 company where Consilience Ventures has invested before Science Angel Syndicate and 1 company where SOSV has invested before Science Angel Syndicate.
- Top Co-investors of Science Angel Syndicate: 33 investors entered a company along with Science Angel Syndicate. These include investors like Elbow Beach Capital (6 companies).
- Invested after Science Angel Syndicate: A total of 17 investors have invested in Science Angel Syndicate's portfolio after their investments. Top Investors include Empirical Ventures (4 companies) and Mishcon de Reya (1 company).
Recent News related to Science Angel Syndicate
•
MitoRx Therapeutics Closes Seed Extension FinancingFinSMEs•Dec 14, 2023•MitoRx Therapeutics, UK Innovation Science & Seed Fund, Wren Capital, Longevitytech.fund and 2 others
•
•
Halo Therapeutics raises £1.5m to bring first antiviral spray into clinicAngel News•Jun 02, 2023•Halo Therapeutics, Development Bank of Wales, Science Angel Syndicate, KBA Group
•
£1.52 Million Boost for Halo Therapeutics as Life-Sciences Business Invests in WalesBusiness News Wales•May 23, 2023•Halo Therapeutics, Development Bank of Wales, Science Angel Syndicate, KBA Group
•
Science Angel Syndicate invests in Halo Therapeutics who raised £1.5m to bring first antiviral spray into clinicUKBAA•May 22, 2023•Halo Therapeutics, Science Angel Syndicate
•
Imperial startup OSSTEC has raised £1.2 million to take its system of smart bone implants into clinical trialsUKBAA•Apr 03, 2023•SFC Capital, OSSTEC, O-Ion Technologies, Science Angel Syndicate and 3 others
•
Ensilicated Technologies Raises £1.2M in Pre-Seed FundingFinSMEs•Jan 17, 2023•EnsiliTech, Science Angel Syndicate, Fink Family Office, QantX and 3 others
•
‘Fridgeless’ vaccine spinout gets £1.2m fundingUKTN•Jan 17, 2023•EnsiliTech, University of Bath, Science Angel Syndicate, Fink Family Office and 3 others
•
UK-based QV Bioelectronics raises £2 million for potential brain tumour treatmentTech.eu•Jan 10, 2023•QV Bioelectronics, Science Angel Syndicate, Fink Family Office, Northern Gritstone and 7 others
•
Chemistry automation startup CheMastery backed by Science Angel syndicateAngel News•Dec 16, 2022•cheMastery, Science Angel Syndicate, Elbow Beach Capital, Britbots and 11 others


